Cuprina Holdings (Cayman) LTD

Cuprina Holdings (Cayman) Limited is a biomedical company focused on chronic wound management solutions. The company manufactures and distributes sterile blowfly larvae bio-dressing products marketed under the MEDIFLY brand, which function as a biological debridement tool for chronic wound treatment. The company is also developing collagen-based dressings in multiple formats including sponges, particles, and hydrogels derived from bullfrog collagen sourced from abattoir waste valorization. Additionally, the company is developing wound treatment products utilizing medical leeches.

The company operates as a subsidiary of Cuprina Holding Pte. Ltd. and maintains headquarters in Singapore. With 14 full-time employees, Cuprina operates at an early-stage scale within the medical devices and supplies sector. The company was incorporated in the Cayman Islands and is publicly listed on Nasdaq, though specific revenue figures and geographic distribution details remain limited.